Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Hair regrowth improved, but quality of life did not.

High beta-hydroxybutyrate levels may worsen hair loss in alopecia areata.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

The treatment was ineffective in humans.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Baricitinib is an effective treatment for severe alopecia areata.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Triamcinolone acetonide is slightly more effective than betamethasone for hair regrowth in localized alopecia areata.

Etanercept effectively treated a severe skin condition when other treatments failed.

Ustekinumab helped three kids with alopecia areata regrow hair.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.